Literature DB >> 9781538

The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study.

B C Jacobs1, P H Rothbarth, F G van der Meché, P Herbrink, P I Schmitz, M A de Klerk, P A van Doorn.   

Abstract

OBJECTIVE: To determine which antecedent infections are specifically associated with the Guillain-Barré syndrome (GBS).
BACKGROUND: Infections with many agents have been reported preceding GBS. Some infections are related to specific clinical and immunologic subgroups in GBS. Most agents were reported in case reports and uncontrolled small series of GBS patients only, and their relation to GBS and its subgroups remains unclear.
METHOD: A serologic study for 16 infectious agents in 154 GBS patients and 154 sex- and age-matched controls with other neurologic diseases. Acute phase, pretreatment samples were used from clinically well-defined GBS patients. The seasonal distribution of serum sampling in the GBS and control group was the same.
RESULTS: Multivariate analysis showed that in GBS patients, infections with Campylobacter jejuni (32%), cytomegalovirus (13%), and Epstein-Barr virus (10%) were significantly more frequent than in controls. Mycoplasma pneumoniae infections occurred more often in GBS patients (5%) than in controls in univariate analysis. Infections with Haemophilus influenzae (1%), parainfluenza 1 virus (1%), influenza A virus (1%), influenza B virus (1%), adenovirus (1%), herpes simplex virus (1%), and varicella zoster virus (1%) were also demonstrated in GBS patients, but not more frequently than in controls. C. jejuni infections were associated with antibodies to the gangliosides GM1 and GD1b and with a severe pure motor form of GBS. Cytomegalovirus infections were associated with antibodies to the ganglioside GM2 and with severe motor sensory deficits. Other infections were not related to specific antiganglioside antibodies and neurologic patterns.
CONCLUSIONS: Recent infections with C. jejuni, cytomegalovirus, Epstein-Barr virus, and M. pneumoniae are specifically related to GBS. The variety of infections may contribute to the clinical and immunologic heterogeneity of GBS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781538     DOI: 10.1212/wnl.51.4.1110

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  174 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

Review 2.  Guillain Barré syndrome.

Authors:  J B Winer
Journal:  Mol Pathol       Date:  2001-12

3.  Recycling doctors.

Authors:  P F Gill
Journal:  Med J Aust       Date:  1975-10-04       Impact factor: 7.738

4.  GB syndrome with herpes simplex infection.

Authors:  S Saraf; R K Singh
Journal:  Indian J Pediatr       Date:  2001-09       Impact factor: 1.967

5.  Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.

Authors:  H P Endtz; C W Ang; N van Den Braak; B Duim; A Rigter; L J Price; D L Woodward; F G Rodgers; W M Johnson; J A Wagenaar; B C Jacobs; H A Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

6.  Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.

Authors:  Christiane Caudie; Arnaud Quittard Pinon; Didier Taravel; Valérie Sivadon-Tardy; David Orlikowski; Flore Rozenberg; Tarek Sharshar; Jean Claude Raphaël; Jean Louis Gaillard
Journal:  J Neurol       Date:  2011-04-24       Impact factor: 4.849

7.  Management of inflammatory neuropathies.

Authors:  Robert D M Hadden; Richard A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

8.  Guillain-Barre syndrome associated with Norovirus infection.

Authors:  Khalid Gailani Eltayeb; Paul Crowley
Journal:  BMJ Case Rep       Date:  2012-06-25

9.  Guillain-Barré syndrome after rtPA therapy for acute stroke.

Authors:  A Bersano; D Santoro; A Prelle; S Lanfranconi; M Ranieri; C S Tadeo; N Bresolin; P L Baron
Journal:  Neurol Sci       Date:  2010-05-08       Impact factor: 3.307

10.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.